| Chemotherapy-induced organ toxicity mitigation | Lifetime | 3 | EG 1 | 99.42 |
| Pesticide Exposure and Toxicity | Lifetime | 26 | EG 1 | 99.37 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 44 | EG 1 | 99.40 |
| Moringa oleifera research and applications | Lifetime | 19 | EG 4 | 99.39 |
| Pharmacological Effects of Natural Compounds | Lifetime | 110 | EG 1 | 98.90 |
| Nigella sativa pharmacological applications | Lifetime | 8 | EG 1 | 98.82 |
| Vitamin C and Antioxidants Research | Lifetime | 168 | EG 1 | 97.49 |
| Garlic and Onion Studies | Lifetime | 132 | EG 2 | 96.11 |
| Medicinal Plants and Neuroprotection | Lifetime | 279 | EG 6 | 94.48 |
| Natural Antidiabetic Agents Studies | Lifetime | 731 | EG 11 | 94.55 |
| Therapeutic Uses of Natural Elements | Lifetime | 224 | EG 2 | 91.86 |
| Seaweed-derived Bioactive Compounds | Lifetime | 885 | EG 7 | 89.86 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 826 | EG 5 | 88.43 |
| Curcumin's Biomedical Applications | Lifetime | 656 | EG 11 | 87.12 |
| Sesame and Sesamin Research | Lifetime | 211 | EG 2 | 84.80 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 682 | EG 9 | 77.84 |
| Coenzyme Q10 studies and effects | Lifetime | 977 | EG 4 | 73.96 |
| Phytochemical and Pharmacological Studies | Lifetime | 933 | EG 10 | 67.49 |
| Paraoxonase enzyme and polymorphisms | Lifetime | 893 | EG 10 | 64.45 |
| Saffron Plant Research Studies | Lifetime | 948 | EG 12 | 60.21 |
| Pharmacological Effects of Natural Compounds | 2021-2025 | 143 | EG 6 | 93.25 |
| Medicinal Plants and Neuroprotection | 2021-2025 | 68 | EG 6 | 93.44 |
| Drug-Induced Hepatotoxicity and Protection | 2021-2025 | 105 | EG 9 | 93.49 |
| Chemotherapy-induced organ toxicity mitigation | 2021-2025 | 31 | EG 10 | 91.70 |
| Natural Antidiabetic Agents Studies | 2021-2025 | 246 | EG 7 | 90.88 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 41 | EG 1 | 89.40 |
| Animal Nutrition and Physiology | 2021-2025 | 869 | EG 43 | 90.53 |
| Potato Plant Research | 2021-2025 | 190 | EG 1 | 83.73 |
| Cholinesterase and Neurodegenerative Diseases | 2021-2025 | 383 | EG 9 | 83.60 |
| Vitamin C and Antioxidants Research | 2021-2025 | 188 | EG 6 | 81.83 |
| Moringa oleifera research and applications | 2021-2025 | 388 | EG 82 | 82.84 |
| Bee Products Chemical Analysis | 2021-2025 | 698 | EG 22 | 82.65 |
| Pesticide Exposure and Toxicity | 2021-2025 | 383 | EG 12 | 78.40 |
| Selenium in Biological Systems | 2021-2025 | 438 | EG 25 | 79.64 |
| Saffron Plant Research Studies | 2021-2025 | 121 | EG 3 | 73.58 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 817 | EG 25 | 70.00 |
| Biochemical Acid Research Studies | 2021-2025 | 177 | EG 6 | 62.59 |
| Medicinal plant effects and applications | 2021-2025 | 203 | EG 4 | 63.17 |
| Sesame and Sesamin Research | 2021-2025 | 202 | EG 5 | 60.21 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 763 | EG 9 | 54.94 |
| Nigella sativa pharmacological applications | 2021-2025 | 300 | EG 26 | 54.98 |
| Healthcare and Venom Research | 2021-2025 | 794 | EG 23 | 53.96 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 500 | EG 12 | 52.62 |
| Phytochemical and Pharmacological Studies | 2021-2025 | 497 | EG 3 | 41.91 |
| Morinda citrifolia extract uses | 2021-2025 | 213 | EG 5 | 40.25 |
